Results 41 to 50 of about 2,423 (205)
Advanced Sensor Research, Volume 5, Issue 4, April 2026.Sensorineural hearing loss (SNHL) occurs in 1.5 billion globally, primary driven by damage of cochlear hair cells and spiral ganglion neurons. This review systematically examines current therapeutic strategies for sensorineural hearing loss, including traditional drug and physical therapies as well as emerging stem cell and gene therapies, providing a ...
Ruirui Chen +3 more
wiley +1 more source
Advanced Science, Volume 13, Issue 20, 9 April 2026.This research identified cardiac amyloid pathology, neurotrophic factor depletion, and reduced myocardial nerve function in a transgenic model of cerebral amyloidosis (Tg2576), Aβ‐challenged cardiomyocytes, and in human AD heart tissue. These findings carry significant diagnostic and therapeutic implications, emphasizing the role of neuro‐signaling ...
Andrea Elia +6 more
wiley +1 more source
Hyperthyroidism incidence in a large population-based study in northeastern Italy
Endocrine Connections, 2023 Objective: An improvement in iodine status in Veneto Region has been documented in the last decade. We aimed at estimating the incidence of hyperthyroidism in the Veneto Region (Italy) over the period 2013–2022.
Simona Censi +6 more
doaj +1 more source
Immunotherapy in Thyroid Cancer: Current Strategies and Challenges
Cancer Medicine, Volume 15, Issue 4, April 2026.ABSTRACT Thyroid cancer is the most common endocrine malignancy, with an increasing global incidence. Despite advances in conventional treatments, such as surgery, radioactive iodine therapy, and TSH suppression, the management of advanced and aggressive forms, such as anaplastic thyroid carcinoma and refractory differentiated thyroid carcinoma ...
Qian Zhang +5 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 3, March 2026.ABSTRACT Amiodarone therapy may induce thyroid dysfunction in approximately 20% of patients, either amiodarone‐induced hypothyroidism (AIH) or thyrotoxicosis (AIT). Both situations may occur at any time during treatment or even months to years after drug withdrawal due to tissue storage with slow systemic release.
Daniela M. Soares, Lia Ferreira
wiley +1 more source
Thyrostatic Drugs in the Treatment of Diffuse Toxic Goiter
Mìžnarodnij Endokrinologìčnij Žurnal, 2013 .
V.I. Pankiv
doaj +1 more source
Society for Maternal‐Fetal Medicine Consult Series #76: Cancer in pregnancy
Pregnancy, Volume 2, Issue 2, March 2026.Abstract Approximately one in 1000 pregnancies is complicated by the diagnosis of cancer each year, and the incidence of cancer among reproductive‐age individuals is increasing. Management of a pregnant person with cancer can be complex and warrants a multidisciplinary approach to care.
Society for Maternal‐Fetal Medicine (SMFM) +6 more
wiley +1 more source
The influence of thyroid disorders on the state of brain’s bioelectrical activity in pregnant women
Mìžnarodnij Endokrinologìčnij ŽurnalBackground. Thyroid disease is the second most common endocrine disorder after diabetes in pregnancy. Thyroid hormones are crucial for the growth and maturation of many target tissues, especially the brain and skeleton.
O.S. Paienok +4 more
doaj +1 more source
Diffusive non-toxic goiter and purbatic course in girls
Репродуктивная эндокринология, 2019 Objective of the study. To study the peculiarities of the puberty course in girls with diffuse non-toxic goiter (DNG) and justify an individual approach to prevention of its disorders. Materials and methods.
С. І. Турчина +1 more
doaj +1 more source
Veterinary Record Case Reports, Volume 14, Issue 1, February 2026.Abstract A 7‐year‐old domestic shorthair cat was presented to a primary veterinarian for evaluation of polydipsia, hyporexia and an unkempt haircoat. The cat was diagnosed with hypothyroidism based on a serum total thyroxine measured at less than 0.5 µg/dL. The cat was prescribed levothyroxine.
Rebecca Saunders
wiley +1 more source